Fibronectin degradation in chronic wounds depends on the relative levels of elastase, α1-proteinase inhibitor, and α2-macroglobulin

Journal of Investigative Dermatology

Volumn 106, Issue 2, 1996, Pages 335-341

  Grinnell, Frederick ^a   Zhu, Meifang ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Proteinases; Venus stasis ulcer

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ELASTASE; FIBRONECTIN; LEUKOCYTE ELASTASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; ULCER; WOUND HEALING;

EID: 0029938994     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12342990     Document Type: Article

References (55)

1. Agren MS: Gelatinase activity during wound healing. Brit J Dermatol 131:634-640, 1994
2. Agren MS, Taplin CJ, Woessner JF Jr, Eaglstein WH, Mertz PM: Collagenase in wound healing: effect of wound age and type. J Invest Dermatol 99:709-714, 1992
3. Alexander CM, Werb Z: Extracellular matrix degradation. In: Hay ED (ed.). Cell Biology of the Extracellular Matrix. 2nd ed. Plenum Press, New York, 1991, pp 255-302
4. Al-Haik N, Lewis DA, Struthers G: Neutral protease, collagenase and elastase activities in synovial fluids from arthritic patients. Agents Actions 15:436-442, 1984
5. Baumstark JS: Studies on the elastase-serum protein interaction II. On the digestion of human α2-macroglobulin, an elastase inhibitor, by elastase. Biochim Biophys Acta 207:318-330, 1970
6. Bennett NT, Schultz GS: Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 166:74-81, 1993
7. Berman M, Manseau E, Law M, Aiken D: Ulceration is correlated with degradation of fibrin and fibronectin at the corneal surface. Invest Opthal Vis Sci 24:1358-1366, 1983
8. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197-250, 1993
9. Bucalo B, Eaglstein WH, Falanga V: Inhibition of cell proliferation by chronic wound fluid. Wound Repair & Regeneration 1:181-186, 1993
10. Bullen EC, Longaker MT, Updike DL, Benton R, Ladin D, Hou Z, Howard EW: Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol 104:236-240, 1995
11. Cawston TE, Weaver L, Coughlan RJ, Kyle MV, Hazleman BL: Synovial fluids from infected joints contain active MMPs and no inhibitory activity. Br J Rheumatol 28:386-392, 1989
12. Chen WYJ, Rogers AA, Lydon MJ: Characterization of biologic properties of wound fluid collected during early stages of wound healing. J Invest Dermatol 99:559-564, 1992
13. Desrivieres S, Lu H, Peyri N, Soria C, Legrand Y, Menashi S: Activation of 92 kDa Type IV collagenase by tissue kallikrein. J Cell Physiol 157:587-593, 1993
14. Doring G: The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 150:s114-s117, 1994
15. Falanga V, Grinnell F, Gilchrest B, Maddox YT, Moshell A: Workshop on the pathogenesis of chronic wounds. J Invest Dermatol 102:125-127, 1994
16. Grinnell F, Ho CH, Wysocki A: Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-416, 1992
17. Grinnell F, Zhu M: Identification of neutrophil elastase as the proteinase in burn wound fluid responsible for degradation of fibronectin. J Invest Dermatol 103:155-161, 1994
18. Grondahl-Hansen J, Lund LR, Ralfkiaer E, Ottevanger V, Dano K: Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 90:790-795, 1988
19. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 261:2814-2818, 1986
20. Hofer HP, Kukovetz E, Petek W, Schweighofer F, Wilkburger R, Schaur RJ: Released PMN elastase: an indicator of postsurgical uneventful wound healing and early inflammatory complications. A contribution to the search for objective criteria in wound healing monitoring. Injury 26:103-106, 1995
21. Inoue M, Kratz G, Haegerstrand A, Stahle-Backdahl M: Collagenase expression is rapidly induced in wound-edge keratinocytes after acute injury in human skin, persists during healing, and stops at re-epithelialization. J Invest Dermatol 104: 479-483, 1995
22. Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS: Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90:777-782, 1988
23. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970
24. Lauharanta J, Salonen E-M, Vaheri A: Plasmin-like proteinase associated with high molecular weight complexes in blister fluid of bullous pemphigoid. Acta Derm Venereol (Stockh) 69:527-529, 1989
25. Laurell C-B, Jeppsson J-O: Protease inhibitors in plasma. In: Putnam FW (ed.). The Plasma Proteins. 2nd ed. Vol. 1. Academic Press, New York, 1975, pp 229-264
26. Lowry OH, Rosebrough N, Farr A, Randall R: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
27. Mehdi S, Angelastro MR, Burkhart JP, Koehl JR, Peet NP, Bey P: The inhibition of human neutrophil elastase and cathepsin G by pepridyl 1,2-dicarbonyl derivatives. Biochem Biophys Res Commun 166:595-600, 1990
28. Murphy G, Bretz U, Baggiolini M, Reynolds JJ: The latent collagenase and gelatinase of human polymorphonuclear neutrophil leukocytes. Biochem J 192:517-525, 1980
29. Nagase H, Itoh Y, Binner S: Interaction of α2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms. Anal N Y Acad Sci 732:294-302, 1994
30. Nishida T, Ohashi Y, Awata T, Manabe R: Fibronectin: a new therapy for corneal trophic ulcer. Arch Opthalmol 101:1046-1048, 1983
31. Ogata Y, Enghild JJ, Nagase H: Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267:3581-3584, 1992
32. Oikarinen A, Kylmaniemi M, Autio-Harmainen H, Autio P, Salo T: Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J Invest Dermatol 101:205-210, 1993
33. Oikarinen AI, Zone JJ, Ahmed AR, Kiistala U, Uitto J: Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetisformis and bullous pemphigoid. J Invest Dermatol 81:261-266, 1983
34. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 267:21712-21719, 1992
35. Okada Y, Nakanishi I: Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (gelatinase) by human neutrophil elastase and cathepsin G. FEBS Lett 249:353-356, 1989
36. Palolahti M, Lauharanta J, Stephens RW, Kuusela P, Vaheri A: Proteolytic activity in leg ulcer exudate. Exp Dermatol 2:29-37, 1993
37. Partsch G, Petera P, Leeb B, Meretey K, Koo E, Dunky A, Broil H, Zamani O, Fertschak W, Matucci-Cerinic M, Smolen JS: High free and latent collagenase activity in psoriatic arthritis synovial fluids. Br J Rheumatol 33:702-706, 1994
38. Petersen CM: α2-macroglobulin and pregnancy zone protein. Dan Med Bull 40:409-446, 1993
39. Porras-Reyes B, Blair HC, Jeffrey JJ, Mustoe TA: Collagenase production at the border of granulation tissue in a healing wound: macrophase and mesenchymal collagenase production in vivo. Conn Tissue Res 27:63-71, 1991
40. Potempa J, Korzus E, Travis J: The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269:15957-15960, 1994
41. Rao CN, Ladin DA, Liu YY, Chilukuri C, Hou ZZ, Woodley DT: Alpha 1-antitrypsin is degraded and non-functional in chronic wounds but intact and functional in acute wounds: the inhibitor protects fibronectin from degradation by chronic wound fluid enzymes. J Invest Dermatol 105:572-578, 1995
42. Romer J, Lund LR, Eriksen J, Ralfkiaer E, Zeheb R, Gelehrter TD, Dano K, Kristensen P: Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. J Invest Dermatol 97:803-811, 1991
43. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 92:2858-2866, 1993
44. Saarialho-Kere UK, Vaalamo M, Airola K, Niemi KM, Oikarinen AI, Parks WC: Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin diseases. J Invest Dermatol 104:982-988, 1995
45. Salo T, Makela M, Kylmniemi M, Autio-Harmainen H, Larjava H: Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Investigation 70:176-182, 1994
46. Salonen EM, Tervo T, Torma E, Tarkkanen A, Vaheri A: Plasmin in tear fluid of patients with corneal ulcers: basis for new therapy. Acta Opthalmol Logica 65:3-12, 1987
47. Schafer BM, Maier K, Eickhoff U, Todd RF, Kramer MD: Plasminogen activation in healing human wounds. Am J Pathol 144:1269-1280, 1994
48. Stacey MC, Burnand KG, Mahmoud-Alexandroni M, Gaffney PJ, Bhogal BS: Tissue and urokinase plasminogen activators in the environs of venous and ischaemic leg ulcers. Br J Surg 80:596-599, 1993
49. Stricklin GP, Li L, Jancic V, Wenczak BA, Nanney LB: Localization of mRNAs representing collagenase and TIMP in sections of healing human burn wounds. Am J Pathol 143:1657-1666, 1993
50. Vissers MC, Winterbourn CC: Activation of human neutrophil gelatinase by endogenous serine proteinases. Biochem J 249:327-331, 1988
51. Williams JC, Falcone RC, Knee C, Stein RL, Strimpler AM, Reaves B, Giles RE, Krell RD: Biologic characterization of ICI 200,880 and ICI 200,355, novel inhibitors of human neutrophil elastase. Am Rev Respir Dis 144:875-883, 1991
52. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-21 54, 1991
53. Wysocki AB, Grinnell F: Fibronectin profiles in normal and chronic wound fluid. Lab Invest 63:825-831, 1990
54. Wysocki AB, Staiano-Coico L, Grinnell F: Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol 101:64-68, 1993
55. Young PK, Grinnell F: Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J Invest Dermatol 103:660-664, 1994